Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NVAX | Common Stock | Options Exercise | +6.97K | +21.87% | 38.8K | Dec 14, 2022 | Direct | F1, F2 | ||
transaction | NVAX | Common Stock | Tax liability | -$40K | -2.32K | -5.98% | $17.23 | 36.5K | Dec 14, 2022 | Direct | F3, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NVAX | Restricted Stock Units | Options Exercise | $0 | -6.97K | -50% | $0.00 | 6.97K | Dec 14, 2022 | Common Stock | 6.97K | Direct | F2, F5 |
Id | Content |
---|---|
F1 | The shares were received by the Reporting Person in connection with vesting of restricted stock units ("RSUs"). |
F2 | Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
F3 | The shares were withheld by the Company to satisfy tax withholding obligations in connection with the vesting of RSUs. |
F4 | The shares reported on this Form 4 are subject to a lock-up agreement between the Reporting Person, J.P. Morgan Securities LLC and Jefferies LLC, dated December 14, 2022. |
F5 | The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date. |